Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
What to do with windfall money debt guidance directs windfall funds to high-impact debts first, creating a faster path to balance reduction.
13,904 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
XRP faces a volatile road ahead as escrow releases, ETF demand, and broader crypto cycles converge. Analysts weigh se...
MacKenzie Scott’s philanthropy dominated megagifts in 2025, representing roughly one-third of the year’s total. New d...
A $10,000 SPY investment made the night of the 2024 election would be worth about $12,600 today, counting dividends. ...
The quantum funding wave from Washington exposes a stark split: IonQ’s rapid revenue growth against IBM’s cash machin...
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Six weeks of fund outflows from US spot BTC ETFs weigh on Bitcoin as the price drops to 21-month lows. Long-term hold...
Amid a regulatory push, centralized venues pull privacy assets from listings, yet GhostSwap keeps Monero and other co...
In 2026, a wave of AI-powered tools is reshaping how agents manage leads, websites, and transactions as the market sh...
Europe endures a blistering heatwave as the U.S. relies on widespread air conditioning. A climate tech executive outl...
Starting with $1,000 doesn’t mean you have to choose between growth and income. This guide shows how to build a relia...
When markets swing, investors ask if XRP is the best crypto right now. This guide breaks down what that label means, ...